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The aims of this study were to evaluate the incidence of invasive pneumococcal disease (IPD) in
Italian children and perform serotyping by PCR-based assays directly on clinical samples. A 1-
year paediatric (0–14 years) population-based surveillance study was designed to evaluate the
incidence of IPD in the province of Florence, Italy, by cultural and molecular methods. Among 92
children (80 with pneumonia, 8 with meningitis/sepsis, 4 with arthritis), 4 cases of IPD were
diagnosed both by culture and real-time PCR and 18 cases exclusively by molecular methods.
The sensitivity of molecular methods was significantly higher than that of cultural methods
(Cohen’s k 0.41; McNemar P50.000008). The incidence of IPD in children below 2 years of age
was 11.5/100000 and 51.8/100000 by cultural and molecular methods, respectively.
Pneumococcal serotyping by multiplex sequential PCR was obtained in 19/22 samples. Real-time
PCR and multiplex sequential PCR can be used directly on biological samples, improving the
ability to diagnose IPD. The incidence of IPD appears 5–10 times higher by PCR than by cultural
methods.
INTRODUCTION
Streptococcus pneumoniae is a major aetiological agent for
pneumonia, meningitis, otitis and sepsis, among both young
children and elderly people all over the world (Black et al.,
2007; CDC, 1997). The organism is the cause of at least 1.2
million deathseach yearin children due to sepsis, meningitis
and pneumonia (CDC, 1997; Hausdorff et al., 2000).
The incidence of invasive pneumococcal disease (IPD)
varies across countries (Domı ´nguez et al., 2002; Smith et al.,
1998; Whitney et al., 2003) and is probably largely
underestimated since diagnosis of invasive pneumococcal
infections, usually performed by culturing from whole
blood or cerebrospinal fluid (CSF), requires the presence of
viable pathogens in the clinical samples. Very few data are
available for Italy, where the only available source is a
passive surveillance system started in 1994 (National
Surveillance System for Bacterial Meningitis) where both
meningitis and sepsis are reported (Italian National
Institute of Health, 2007; http://www.simi.iss.it/dati.htm).
According to that system, the mean incidence rate for
meningitis seems to be around 0.5/100000 (Italian
National Institute of Health, 2007; http://www.simi.iss.
it/dati.htm). A prospective surveillance of IPD was
undertaken in two Italian regions in 2001 by standard
cultural methods and the highest incidence recorded for
children was 6–11/100000 for children below 2 years of age
(D’Ancona et al., 2005).
PCR-based assays for direct detection of pneumococci
from clinical samples do not require viable bacteria and
reach a very high sensitivity, representing an important
tool in the diagnosis of invasive pneumococcal infections
(Clarke, 2006). However, up to now, PCR-based methods
on clinical samples have been used to discriminate between
pneumococci and other pathogens (Corless et al., 2001)
but not for pneumococcal serotyping. Serotype distri-
bution is usually monitored by serological determination
of the capsular type by standard capsular tests after culture
(D’Ancona et al., 2005) or by molecular serotyping of
isolates (Pai et al., 2006; Kong et al., 2006), so that
pneumococcal serotyping cannot be performed on culture-
negative samples.
The aim of the present study was to evaluate the incidence
of IPD through a 1-year paediatric population-based
Abbreviations: CSF, cerebrospinal fluid; IPD, invasive pneumococcal
disease; RT, real-time.
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pneumococcal serotyping using molecular methods
directly on clinical samples.
METHODS
Study design. An observational, prospective, cohort study was
designed to evaluate the incidence of IPD in a paediatric population
in the province of Florence, Italy, in a 12-month period between 1
December 2005 and 30 November 2006. The study was performed
using a molecular diagnostic method, set up in the Laboratory of
Paediatric Immunology of the University of Florence, directly on
biological samples.
Patients. All children 0–14 years referred to the Anna Meyer
Children’s Hospital were considered. The Anna Meyer Children’s
Hospital is the only hospital in the district of Florence in which a
paediatric infectiousdisease unit and a paediatric intensive care unit are
present, and it is the only one in the province where patients with
meningitis, sepsis, arthritis or osteomyelitis as well as with complicated
pneumonia are admitted. The Anna Meyer Children’s Hospital is also a
third level hospital and accepts patients from all of Tuscany and other
Italianregions.Thus,inordertoavoidoverestimationofpneumococcal
incidence, all analyses were uniquely calculated on the basis of the
cohort of residents in the district of Florence (Italian National Institute
of Statistics, ISTAT, 2007; http://demo.istat.it/). All Florentine children
with fever, leukocytosis and/or increased levels of serum C-reactive
protein and a clinical diagnosis of meningitis, sepsis, complicated
pneumonia, osteomyelitis or arthritis were included in the study. Sepsis
was clinically suspected by the presence of previously described signs
and confirmed by blood tests (Russell, 2006). Meningitis was clinically
suspected by the presence of a compatible clinical syndrome and
confirmed by chemical (Overturf, 2005) and microbiological CSF tests
(cultural or molecular testing). Osteomyelitis or arthritis were clinically
suspected by the presence of local signs (Kaplan, 2005) and confirmed
by radiological procedures. Complicated pneumonia was suspected in
the presence of clinical signs such as tachypnoea and pathological
breath sounds (Ostapchuk et al., 2004) and confirmed by X-ray
consistent with pneumonia and demonstrating lobar or segmental lung
consolidation withorwithout pleuraleffusion.AnIPD case was defined
as one in a child admitted to Anna Meyer Children’s Hospital in the
study period with one of the above-mentioned diseases and a
laboratory-confirmed presence of S. pneumoniae in whole blood and/
or CSF and/or pleural fluid by cultural and/or molecular tests. Clinical
conditions preceding the present episode, previous vaccinations and
any underlying disease were recorded. Informed consent was obtained
for their child by parents or guardians.
Data sources. Data concerning children 0–14 years, resident in the
district of Florence, were provided by the National Institute of
Statistics (Italian National Institute of Statistics, ISTAT, 2007; http://
demo.istat.it/).
Vaccination. In the province of Florence, as well as in the whole
Tuscan region, pneumococcal vaccination is not included in the
vaccination schedule for the paediatric or adult population.
Conjugate vaccine is sometimes suggested by individual paediatri-
cians mainly for infants attending day-care centres; vaccination
expenses (both vaccine and administration expenses) are paid by the
families with a co-payment system.
Clinical samples. Whole blood was obtained from all children
included in the study; CSF was obtained from children with a clinical
suspicion of meningitis. Pleural fluid was obtained from two patients
who needed a pleural drainage. Biological samples were obtained as
soon as possible after hospital admission and used both for cultural
testing and for molecular testing by real-time (RT)-PCR and
multiplex sequential PCR.
DNA extraction. Bacterial genomic DNA was extracted from 200 ml
of biological samples using the QIAmp DNeasy Blood & Tissue kit
(Qiagen), according to the manufacturer’s instructions.
RT-PCR. Primers and probes were designed using the ABI Primer
Express Software Package based on previously published ctrA, bexA,
and lytA sequences from the meningococcal capsular transfer gene,
from the Haemophilus influenzae capsule exporting gene and from the
pneumococcal autolysin gene, respectively. The ctrA sequence-specific
probe was FAM-labelled, the bexA probe was NED-labelled, and the
lytA probe was JOE-labelled. Primer and probe sequences are shown
in Table 1. The RT amplification was performed in 25 ml reaction
volumes containing 2 6 TaqMan Universal Master Mix (Applied
Biosystems); primers (for S. pneumoniae, Neisseria meningitidis and
H. influenzae type b) were used at a concentration of 300 nM; the
FAM-labelled probe was used at a concentration of 25 nM and NED-
or JOE-labelled probes were used at a concentration of 50 nM. Six
microlitres of DNA extract was used for each reaction. All reactions
were performed in triplicate. A negative control (no template) and a
positive control for each pathogen were included in every run. DNA
was amplified in an ABI 7000 sequence detection system (Applied
Biosystems) using the following cycling parameters: 95 uC for 10 min
followed by 45 cycles of a two-stage temperature profile of 95 uC for
15 s and 60 uC for 1 min.
Serotyping. S. pneumoniae serotyping was performed on RT-PCR
positive samples through a sequential multiplex PCR on DNA
extracted from biological samples as for RT-PCR. Thirty-one primer
pairs (Pai et al., 2006; O’Halloran & Cafferkey, 2005) for serogroups/
serotypes 1, 3, 4, 5, 6A/B, 7F/A, 7C/B, 8, 9V/A, 10A, 11A/D/F, 12A/B/
F, 14, 15A, 15B/C, 16F, 17F, 18A/B/C/F (two pairs of primers), 19A,
19F, 20, 22A/F, 23F, 31, 33A/F, 34, 35B, 35F and 38F were grouped
into nine multiplex reactions. cpsA (pneumococcal capsular polysac-
Table 1. Primer and probe sequences for RT-PCR
Gene Forward primer Reverse primer Probe
lytA 59-ACGCAATCTAGCAGATGAAGC-39 59-TGTTTGGTTGGTTATTCGTGC-39 59(JOE)-TTTGCCGAAAACGCTTGATACAGGG-6-
carboxytetramethyl-rhodamine (TAMRA)-39
ctrA 59-GCTGCGGTAGGTGGTTCAA-39 59-TTGTCGCGGATTTGCAACTA-39 6-FAM-
680-CATTGCCACGTGTCAGCTGCA-
CAT-
657-6-carboxytetramethyl-rhodamine
(TAMRA)-39
bexA 59-GGCGAAATGGTGCTGGTAA-3 59-GGCCAAGAGATACTCATAGAA-
CGTT-39
NED-CACCACTCATCAAACGAATGAGCGTGG-6-
carboxytetramethyl-rhodamine (TAMRA)-39
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each reaction mix as a confirmatory test; samples positive for
serogroup 14 were also tested for confirmation with a different primer
pair (http://www.cdc.gov/ncidod/biotech/strep/pcr.htm). The PCRs
were performed in 25 ml volumes, with the mixture containing 1 6
PCR Master Mix (Qiagen) and primers (0.2–0.5 mM each); 5 ml DNA
extract was used in each PCR. Amplification was performed in a
Perkin-Elmer GeneAmp PCR system 2720 (Applied Biosystems)
under the following conditions: 95 uC for 15 min followed by 35
amplification cycles of 94 uC for 30 s, 54 uC for 90 s and 72 uC for
60 s. A final hold was performed at 72 uC for 10 min. As previously
described (Kaplan et al., 2004), pneumococcal serotypes were
classified as ‘vaccine serotype’ if they were 4, 6B, 9V, 14, 18C, 19F
or 23F. They were classified as ‘potentially cross-reactive serotypes’ if
they were from the same serogroups but serotype could not be
identified and they were classified as ‘non-vaccine serotypes’ if
samples were positive for serogroups different from those contained
in the heptavalent conjugate vaccine.
PCR product detection. The PCR products were analysed by gel
electrophoresis on 2% NuSieve agarose gels (Cambrex Bio Science) in
1 6 TAE buffer. Gels were stained with ethidium bromide (0.5 mg
ml
21), and gel images were recorded. The sizes of the PCR products
were determined by comparison with the molecular size standard
(100 bp ladder; Novagen).
Microbiology. Blood cultures were performed in BACTEC TM PLUS
aerobic bottles (Becton Dickinson). Identification of the pneumo-
coccal isolates was obtained by conventional techniques (Arbique et
al., 2004), including optochin susceptibility and bile solubility;
serotyping was only performed by molecular methods.
Statistical analysis. All continuous variables were expressed as
mean±SD. Fisher’s exact test, Pearson’s chi-square test and the
McNemar test were used when appropriate. All P values were two-
sided, and values less than 0.05 were considered statistically
significant. SPSSX version 10.1 was used to analyse data.
RESULTS AND DISCUSSION
Children with and without IPD
Ninety-two children [53 males (57.6%), 39 females
(42.4%), ratio 1.36] were included in the study, 80 with
pneumonia, 8 with meningitis/sepsis and 4 with arthritis.
Twenty-two IPD cases [12/53 males (22.6%), 10/39
(25.6%) females (P5NS)] were diagnosed in biological
samples during the 1-year period by RT-PCR and
confirmed by cpsA positivity during the serotyping
procedure with multiplex sequential PCR. Blood samples
were positive by molecular methods in all 22 patients; 3/3
CSF samples obtained from patients with meningitis and 2/
2 pleural fluid samples obtained from patients with
pneumonia were also positive. The distribution of cases
with a different disease is presented in Table 2. White blood
cell count, neutrophil percentage and C-reactive protein
did not differ between IPD and non-IPD patients
(respectively 19956±10168 vs 21447±10378 P5NS;
73.1±25.6 vs 76.3±18.4 P5NS; 16.3±12.5 vs 12.6±10.4
P5NS; normal value for C-reactive protein is ,0.3 mg
dl
21). None of the children with IPD had an underlying
disease. All were previously healthy. The clinical outcome
was evaluated in all 22 cases: no case of death was recorded
but one patient suffered a permanent sequela (partial
cranial nerves palsy) after pneumococcal meningitis.
Serotyping
Molecular methods allowed serotyping (Table 3) in 19/22
patients (86.4%). The impossibility of serotyping can
derive from the presence of serotypes which are not
included in the mix used or from a bacterial load below the
limit of sensitivity of multiplex PCR. In accord with
previously reported data (Corless et al., 2001), in the three
patients that could not be serotyped by the multiplex PCR,
the cycle number to reach the baseline threshold value in
RT-PCR was always higher than 35, suggesting a very low
bacterial load. In patients in whom two biological samples
[blood+CFS (n53) or blood+pleural fluid (n52)] were
available, the same serotype was found in the two different
biological samples. Four of the 19 patients had been
vaccinated; they had pneumonia due to non-vaccine
serotypes. Fifteen children were not vaccinated: 12 (80%)
were infected by vaccine serotypes or by cross-reactive
Table 2. PCR and culture results for Streptococcus pneumoniae in 92 patients
No positivity for other micro-organisms was obtained by cultural methods for any of the samples indicated as negative.
Patients (n592) PCR results for S. pneumoniae n (%) Culture results for S. pneumoniae n (%)
Arthritis 4 Positive 2/4 (50) Positive 1/4 (25)
Negative 2/4 (50) Negative 3/4* (75)
Pneumonia 80 Positive 16/80 (20) Positive 1/80 (1.25)
Negative 64/80 (80) Negative 79/80 (98.75)
Meningitis/sepsis 8 Positive 4/8 (50) Positive 2/8 (25)
Negative 4/8 (50)D Negative 6/8 (75)d
*One was positive for Staphylococcus aureus.
DFour were positive for N. meningitidis.
dOne was positive for N. meningitidis.
Pneumococcal incidence by PCR
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serotypes. All children with major diseases (meningitis/
sepsis) were not vaccinated and were infected by vaccine
serotypes or cross-reactive serotypes. At best, cultural
methods would have serotyped 4/22 (18.2%) patients, thus
giving less informative epidemiological data. The use of
molecular methods for diagnosis of IPD is well documen-
ted (Corless et al., 2001; McAvin et al., 2001; Verhelst et al.,
2003; Morrison et al., 2000) but, up to now, pneumococcus
typing by molecular methods has been performed only on
cultural isolates and not on clinical samples (Pai et al.,
2006; Kong et al., 2006). Therefore, the possibility of
serotyping was restricted to samples positive in culture.
Among the 22 patients with pneumococcal infection
diagnosed by molecular methods, 11/22 (2 meningitis, 9
pneumonia) had received antibiotic therapy before hospital
admission. The two patients with meningitis had both
received a 2 day antibiotic course with cefixime. The nine
patients with pneumococcal pneumonia had received
antibiotic therapy for a mean duration of 4.11 days (range
1–11 days) with amoxicillin+clavulanic acid (three cases),
ceftriaxone (three cases), cefixime (one case), cefixime and
teicoplanin (one case). None of the patients who had
received antibiotic therapy were positive by cultural
methods. Antibiotic therapy is often performed in children
with febrile illnesses on an outpatient basis, before hospital
admission. For this reason, micro-organism viability may
be compromised and cultural methods may be unable to
detect invasive pneumococcus infection (Corless et al.,
2001; Dalton & Allison, 1968) or other bacterial infection
(Kaczmarski, 1997). On the contrary, PCR-based assays,
not requiring viable bacteria, can be successfully used with
patients after the beginning of antibiotic therapy. We are
aware that positive results of molecular tests in blood may
be the results of DNA-aemia and not bacteraemia; however,
the association of compatible clinical syndromes with
positive results of molecular tests in samples obtained from
normally sterile sites (blood, CSF, pleural fluid) appears to
strongly suggest an invasive bacterial infection.
Age distribution and incidence of IPD
The mean age of patients included in the study was
63.1±45.2 months (median 52.5 months, range 1–168
Table 3. Serotype distribution in 22 IPD patients according to type of disease and vaccination status
PF, pleural fluid.
Age (months) Vaccinated Culture result RT-PCR results (gene lytA) Serotyping
Blood CSF PF PCR with serotype-
specific primers*
PCR for
gene cps
Arthritis (n52) 6 No POS NT POS
10 No POS POS 22F POS
Pneumonia (n516) 85 No POS 4 POS
24 No POS POS 6A/B POS
1 No POS 6A/B POS
22 Yes POS 19A POS
22 No POS 8 POS
38 No POS 8 POS
4 No POS NT POS
11 No POS 14 POS
70 No POS 18 POS
108 No POS POS POS 18CD POS
51 No POS NT POS
55 Yes POS 1 POS
71 No POS 19F POS
63 Yes POS 12 POS
43 Yes POS 3 POS
50 No POS 19F POS
Meningitis/sepsis (n54) 19 No POS POS 4 POS
38 No POS POS 6A/B POS
120 No POS POS POS 23F POS
80 No POS POS 9V/A POS
*NT, Non-typeable.
DCulture confirmed.
C. Azzari and others
1208 Journal of Medical Microbiology 57months). The mean age of IPD patients was 45.0±33.8
months (median 40.5 months, range 1–120 months) and
that of non-IPD patients was 70.3±47.6 months (median
60.0 months, range 1–168 months). IPD patients were
significantly younger than non-IPD patients (P50.01, 95%
CI56.8–44.0). The age distribution of IPD patients is
shown in Fig. 1. The Florentine paediatric population
below 14 years of age was 110727, of which 8963 were
below 1 year, 17385 below 2 years of age and 42756 below
5 years of age (Italian National Institute of Statistics,
ISTAT, 2007; http://demo.istat.it/). Larger studies are
necessary to give a correct estimate of IPD incidence in
relation to paediatric age; however, the present data suggest
a higher frequency of IPD when evaluated by molecular
methods. The incidence rate for IPD obtained by cultural
methods was 3.6/100000 for children below 14 years, 4.7/
100000 under 5 years, 11.5/100000 under 2 years and 11.2/
100000 in the first year of life. Using molecular methods,
the incidence rate of IPD in children below 14 years of age
was 19.9/100000, the incidence below 5 years of age was
35.1/100000, below 2 years was 51.8/100000 and below 1
year was 55.8/100000 (Fig. 2). The present data confirm
that, as in other countries in the world (D’Ancona et al.,
2005; Kaltoft et al., 2000; von Kries et al., 2000; Black et al.,
2004), the highest incidence of IPD is found in children
below 2 years of age and it progressively declines with
increasing paediatric age. IPD incidence in children below
2 years obtained in the present study by cultural methods is
similar to data previously reported in Italy (D’Ancona et
al., 2005) and in other countries in the world (Gendrel et
al., 1997; Juve ´n et al., 2000; Esposito et al., 2004). The
present study suggests that IPD incidence in the paediatric
population of the Florentine area, evaluated by molecular
methods, appears significantly higher, exceeding 50/
100000 in children below 2 years and even higher in
children in the first year of life. As demonstrated by
Rodrı ´guez-Cre ´ixems et al. (2003), the incidence of invasive
pneumococcal infection is probably even higher than that
shown by present results. Indeed patients with fever, often
associated with pneumococcal occult bacteraemia
(Carvalho et al., 2007), have not been included.
Moreover, the present study evaluated only patients
admitted to hospital, while patients with pneumonia are
usually followed on an outpatient basis. Therefore, the
present data are complementary to those obtained by
family paediatricians. The main aim of the present study
was to evaluate the incidence of invasive pneumococcal
infection in the paediatric population, so no data on other
aetiological agents responsible for pneumonia cases were
collected. The IPD incidence relative to the different
diseases studied was 3.6/100000 for meningitis/sepsis, 1.8/
100000 for arthritis and 14.4/100000 for pneumonia in
children below 14 years of age (Fig. 2).
PCR sensitivity
None of the patients negative for pneumococcus by RT-
PCR were positive by cultural methods; among the 22
patients who were positive for pneumococcus by molecular
methods, 4/22 (18.2%) were also positive by cultural
methods (Table 2). RT-PCR appeared significantly more
sensitive than culture in diagnosing IPD (Cohen’s k 0.41;
McNemar P50.000008). The four S. pneumoniae isolates
were penicillin-susceptible. For 18/22 (81.8%) patients,
diagnosis of IPD was only obtained by RT-PCR. In
particular, among patients with pneumococcal meningitis
or sepsis, 2/4 (50.0%) were only positive by RT-PCR, while
among patients with pneumococcal pneumonia, 15/16
(93.8%) were only positive by RT-PCR. Of the two
patients with arthritis who were positive for S. pneumoniae
by RT-PCR, one was positive by cultural methods.
Increased sensitivity of molecular methods is even more
evident in patients with pneumonia than in patients with
meningitis/sepsis. For meningitis, the molecular test
routinely performed in our laboratory can diagnose both
S. pneumoniae and N. meningitidis, and 8/8 meningitis/
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organisms. The sensitivity of RT-PCR is double that of
culture in the diagnosis of meningitis/sepsis and it is about
ten times higher in patients with pneumonia. The
difference between the two groups of patients can be
explained in two ways: (i) patients with meningitis and
sepsis usually have a much higher bacterial load, as
demonstrated by RT-PCR (data not shown), so that
cultural methods, though less sensitive, can detect
infection; (ii) patients with meningitis/sepsis usually have
a rapid progression of the disease, becoming severe in a few
hours, so it is less probable that they have received
prolonged antibiotic therapy before hospital admission.
RT-PCR and multiplex sequential PCR are very sensitive
methods and their use on clinical samples can help in
obtaining a closer estimate of the real incidence of IPD.
However, when a positive result is obtained in samples
considered negative by the established ‘gold standard’
(culture from blood or CSF), it might be speculated that
this is due to poor specificity of PCR rather than improved
sensitivity. For this reason, for every sample, we used two
different targets from two unrelated genes, lytA (known to
be extremely sensitive and specific) (Carvalho et al., 2007)
in RT-PCR and cps in sequential multiplex PCR. Positive
results from both targets in the same sample enhance
confidence in the sample positivity. Moreover, more than
80% of the samples could also be serotyped using specific
primers for each serotype, different from those for cps and
lytA. At present, cultural methods remain absolutely
necessary. First, cultural methods can give important data
on antibiotic resistance and individual pathogens which are
not included in molecular protocols. Moreover, in some
cases, the molecular methods described in the present
paper cannot distinguish between serotypes within the
same serogroup (i.e. 6A/6B) and more expensive and time-
consuming molecular tests would be necessary (Pai et al.,
2005). Even if discriminating between serotypes may
sometimes be irrelevant for a clinical approach, because a
vaccine-induced cross-protection is well known
(Vakevainen et al., 2001), distinguishing between serotypes
is undoubtedly useful for correct epidemiological evalu-
ation.
At present, case definition of IPD in many countries is
based on positive results of standard cultural methods
(Pebody et al., 2006). Given that, in many cases, molecular
methods show a higher sensitivity (Corless et al., 2001; Van
Gastel et al., 2007; Lahti et al., 2006), it could be suggested
that case definition should also include diagnosis per-
formed by molecular methods. Indeed, inclusion of
molecular assays in the diagnostic tests would improve
the diagnostic ability and case ascertainment of invasive
bacterial infections.
In conclusion, even though larger studies are required to
confirm the present results on IPD incidence, this study
demonstrates, for the first time, that an association
between RT-PCR and multiplex sequential PCR can be
used directly on biological samples for diagnosis and
serotyping of IPD. It is likely that similar methods can be
used to develop PCR assays able to detect all clinically
relevant pneumococcal serotypes that may be found in
IPD. The method will be helpful in epidemiological
evaluation of circulating serotypes and, consequently, in
making correct decisions about vaccination. Molecular
methods will also be helpful, even after mass vaccination
starts, in monitoring possible epidemiological changes in
serotype distribution.
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